[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Endocrine System Drugs Market Report 2018

March 2018 | 100 pages | ID: U260FF97E84QEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Endocrine System Drugs market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Endocrine System Drugs in these regions, from 2013 to 2025 (forecast).
United States Endocrine System Drugs market competition by top manufacturers/players, with Endocrine System Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Novo Nordisk
  • Sanofi
  • Merck
  • Eli Lilly
  • AstraZeneca
  • AbbVie
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Diabetes Drug
  • Human Growth Hormones
  • Thyroid Hormone Disorder Drugs
  • Other
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Hospitals
  • Clinics
  • Medical Center
  • Other
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Endocrine System Drugs Market Report 2018

1 ENDOCRINE SYSTEM DRUGS OVERVIEW

1.1 Product Overview and Scope of Endocrine System Drugs
1.2 Classification of Endocrine System Drugs by Product Category
  1.2.1 United States Endocrine System Drugs Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Endocrine System Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 Diabetes Drug
  1.2.4 Human Growth Hormones
  1.2.5 Thyroid Hormone Disorder Drugs
  1.2.6 Other
1.3 United States Endocrine System Drugs Market by Application/End Users
  1.3.1 United States Endocrine System Drugs Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Hospitals
  1.3.3 Clinics
  1.3.4 Medical Center
  1.3.5 Other
1.4 United States Endocrine System Drugs Market by Region
  1.4.1 United States Endocrine System Drugs Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Endocrine System Drugs Status and Prospect (2013-2025)
  1.4.3 Southwest Endocrine System Drugs Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Endocrine System Drugs Status and Prospect (2013-2025)
  1.4.5 New England Endocrine System Drugs Status and Prospect (2013-2025)
  1.4.6 The South Endocrine System Drugs Status and Prospect (2013-2025)
  1.4.7 The Midwest Endocrine System Drugs Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Endocrine System Drugs (2013-2025)
  1.5.1 United States Endocrine System Drugs Sales and Growth Rate (2013-2025)
  1.5.2 United States Endocrine System Drugs Revenue and Growth Rate (2013-2025)

2 UNITED STATES ENDOCRINE SYSTEM DRUGS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Endocrine System Drugs Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Endocrine System Drugs Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Endocrine System Drugs Average Price by Players/Suppliers (2013-2018)
2.4 United States Endocrine System Drugs Market Competitive Situation and Trends
  2.4.1 United States Endocrine System Drugs Market Concentration Rate
  2.4.2 United States Endocrine System Drugs Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Endocrine System Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES ENDOCRINE SYSTEM DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Endocrine System Drugs Sales and Market Share by Region (2013-2018)
3.2 United States Endocrine System Drugs Revenue and Market Share by Region (2013-2018)
3.3 United States Endocrine System Drugs Price by Region (2013-2018)

4 UNITED STATES ENDOCRINE SYSTEM DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Endocrine System Drugs Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Endocrine System Drugs Revenue and Market Share by Type (2013-2018)
4.3 United States Endocrine System Drugs Price by Type (2013-2018)
4.4 United States Endocrine System Drugs Sales Growth Rate by Type (2013-2018)

5 UNITED STATES ENDOCRINE SYSTEM DRUGS SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Endocrine System Drugs Sales and Market Share by Application (2013-2018)
5.2 United States Endocrine System Drugs Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES ENDOCRINE SYSTEM DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Novo Nordisk
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Endocrine System Drugs Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Novo Nordisk Endocrine System Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Sanofi
  6.2.2 Endocrine System Drugs Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Sanofi Endocrine System Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Merck
  6.3.2 Endocrine System Drugs Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Merck Endocrine System Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Eli Lilly
  6.4.2 Endocrine System Drugs Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Eli Lilly Endocrine System Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 AstraZeneca
  6.5.2 Endocrine System Drugs Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 AstraZeneca Endocrine System Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 AbbVie
  6.6.2 Endocrine System Drugs Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 AbbVie Endocrine System Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview

7 ENDOCRINE SYSTEM DRUGS MANUFACTURING COST ANALYSIS

7.1 Endocrine System Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Endocrine System Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Endocrine System Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Endocrine System Drugs Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES ENDOCRINE SYSTEM DRUGS MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Endocrine System Drugs Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Endocrine System Drugs Sales Volume Forecast by Type (2018-2025)
11.3 United States Endocrine System Drugs Sales Volume Forecast by Application (2018-2025)
11.4 United States Endocrine System Drugs Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.


LIST OF TABLES AND FIGURES

Figure Product Picture of Endocrine System Drugs
Figure United States Endocrine System Drugs Market Size (K Pcs) by Type (2013-2025)
Figure United States Endocrine System Drugs Sales Volume Market Share by Type (Product Category) in 2017
Figure Diabetes Drug Product Picture
Figure Human Growth Hormones Product Picture
Figure Thyroid Hormone Disorder Drugs Product Picture
Figure Other Product Picture
Figure United States Endocrine System Drugs Market Size (K Pcs) by Application (2013-2025)
Figure United States Sales Market Share of Endocrine System Drugs by Application in 2017
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Clinics Examples
Table Key Downstream Customer in Clinics
Figure Medical Center Examples
Table Key Downstream Customer in Medical Center
Figure Other Examples
Table Key Downstream Customer in Other
Figure United States Endocrine System Drugs Market Size (Million USD) by Region (2013-2025)
Figure The West Endocrine System Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Endocrine System Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Endocrine System Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Endocrine System Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Endocrine System Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Endocrine System Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Endocrine System Drugs Sales (K Pcs) and Growth Rate (2013-2025)
Figure United States Endocrine System Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Endocrine System Drugs Market Major Players Product Sales Volume (K Pcs) (2013-2018)
Table United States Endocrine System Drugs Sales (K Pcs) of Key Players/Suppliers (2013-2018)
Table United States Endocrine System Drugs Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Endocrine System Drugs Sales Share by Players/Suppliers
Figure 2017 United States Endocrine System Drugs Sales Share by Players/Suppliers
Figure United States Endocrine System Drugs Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Endocrine System Drugs Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Endocrine System Drugs Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Endocrine System Drugs Revenue Share by Players/Suppliers
Figure 2017 United States Endocrine System Drugs Revenue Share by Players/Suppliers
Table United States Market Endocrine System Drugs Average Price (USD/Pcs) of Key Players/Suppliers (2013-2018)
Figure United States Market Endocrine System Drugs Average Price (USD/Pcs) of Key Players/Suppliers in 2017
Figure United States Endocrine System Drugs Market Share of Top 3 Players/Suppliers
Figure United States Endocrine System Drugs Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Endocrine System Drugs Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Endocrine System Drugs Product Category
Table United States Endocrine System Drugs Sales (K Pcs) by Region (2013-2018)
Table United States Endocrine System Drugs Sales Share by Region (2013-2018)
Figure United States Endocrine System Drugs Sales Share by Region (2013-2018)
Figure United States Endocrine System Drugs Sales Market Share by Region in 2017
Table United States Endocrine System Drugs Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Endocrine System Drugs Revenue Share by Region (2013-2018)
Figure United States Endocrine System Drugs Revenue Market Share by Region (2013-2018)
Figure United States Endocrine System Drugs Revenue Market Share by Region in 2017
Table United States Endocrine System Drugs Price (USD/Pcs) by Region (2013-2018)
Table United States Endocrine System Drugs Sales (K Pcs) by Type (2013-2018)
Table United States Endocrine System Drugs Sales Share by Type (2013-2018)
Figure United States Endocrine System Drugs Sales Share by Type (2013-2018)
Figure United States Endocrine System Drugs Sales Market Share by Type in 2017
Table United States Endocrine System Drugs Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Endocrine System Drugs Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Endocrine System Drugs by Type (2013-2018)
Figure Revenue Market Share of Endocrine System Drugs by Type in 2017
Table United States Endocrine System Drugs Price (USD/Pcs) by Types (2013-2018)
Figure United States Endocrine System Drugs Sales Growth Rate by Type (2013-2018)
Table United States Endocrine System Drugs Sales (K Pcs) by Application (2013-2018)
Table United States Endocrine System Drugs Sales Market Share by Application (2013-2018)
Figure United States Endocrine System Drugs Sales Market Share by Application (2013-2018)
Figure United States Endocrine System Drugs Sales Market Share by Application in 2017
Table United States Endocrine System Drugs Sales Growth Rate by Application (2013-2018)
Figure United States Endocrine System Drugs Sales Growth Rate by Application (2013-2018)
Table Novo Nordisk Basic Information List
Table Novo Nordisk Endocrine System Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Novo Nordisk Endocrine System Drugs Sales Growth Rate (2013-2018)
Figure Novo Nordisk Endocrine System Drugs Sales Market Share in United States (2013-2018)
Figure Novo Nordisk Endocrine System Drugs Revenue Market Share in United States (2013-2018)
Table Sanofi Basic Information List
Table Sanofi Endocrine System Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Sanofi Endocrine System Drugs Sales Growth Rate (2013-2018)
Figure Sanofi Endocrine System Drugs Sales Market Share in United States (2013-2018)
Figure Sanofi Endocrine System Drugs Revenue Market Share in United States (2013-2018)
Table Merck Basic Information List
Table Merck Endocrine System Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Merck Endocrine System Drugs Sales Growth Rate (2013-2018)
Figure Merck Endocrine System Drugs Sales Market Share in United States (2013-2018)
Figure Merck Endocrine System Drugs Revenue Market Share in United States (2013-2018)
Table Eli Lilly Basic Information List
Table Eli Lilly Endocrine System Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Eli Lilly Endocrine System Drugs Sales Growth Rate (2013-2018)
Figure Eli Lilly Endocrine System Drugs Sales Market Share in United States (2013-2018)
Figure Eli Lilly Endocrine System Drugs Revenue Market Share in United States (2013-2018)
Table AstraZeneca Basic Information List
Table AstraZeneca Endocrine System Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure AstraZeneca Endocrine System Drugs Sales Growth Rate (2013-2018)
Figure AstraZeneca Endocrine System Drugs Sales Market Share in United States (2013-2018)
Figure AstraZeneca Endocrine System Drugs Revenue Market Share in United States (2013-2018)
Table AbbVie Basic Information List
Table AbbVie Endocrine System Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure AbbVie Endocrine System Drugs Sales Growth Rate (2013-2018)
Figure AbbVie Endocrine System Drugs Sales Market Share in United States (2013-2018)
Figure AbbVie Endocrine System Drugs Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Endocrine System Drugs
Figure Manufacturing Process Analysis of Endocrine System Drugs
Figure Endocrine System Drugs Industrial Chain Analysis
Table Raw Materials Sources of Endocrine System Drugs Major Players/Suppliers in 2017
Table Major Buyers of Endocrine System Drugs
Table Distributors/Traders List
Figure United States Endocrine System Drugs Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure United States Endocrine System Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Endocrine System Drugs Price (USD/Pcs) Trend Forecast (2018-2025)
Table United States Endocrine System Drugs Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States Endocrine System Drugs Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States Endocrine System Drugs Sales Volume (K Pcs) Forecast by Type in 2025
Table United States Endocrine System Drugs Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States Endocrine System Drugs Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States Endocrine System Drugs Sales Volume (K Pcs) Forecast by Application in 2025
Table United States Endocrine System Drugs Sales Volume (K Pcs) Forecast by Region (2018-2025)
Table United States Endocrine System Drugs Sales Volume Share Forecast by Region (2018-2025)
Figure United States Endocrine System Drugs Sales Volume Share Forecast by Region (2018-2025)
Figure United States Endocrine System Drugs Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories